| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 04/17/2013 | CN101289510B 抗cd40单克隆抗体 Monoclonal antibody anti-cd40 |
| 04/16/2013 | US8420885 Determining the capability of a test compound to affect solid tumor stem cells |
| 04/16/2013 | US8420795 Human IgM antibodies, and diagnostic and therapeutic uses thereof particularly in the central nervous system |
| 04/16/2013 | US8420789 Method for removing DNA contaminants from a protein-containing sample |
| 04/16/2013 | US8420788 Epitopes derived from SATB2 and uses thereof |
| 04/16/2013 | US8420786 Bispecific antibody targeting a complement factor or complement regulatory protein |
| 04/16/2013 | US8420785 Soluble human ST-2 antibodies and assays |
| 04/16/2013 | US8420784 Interleukin 10 receptor, (IL-10R) antibodies |
| 04/16/2013 | US8420783 Multispecific immunoglobulin which targets cells expressing cluster of differentiation-20 and 40 antigens for use in diagnosis, prevention and treatment of cell proliferative, respiratory, autoimmune, respiratory and atheroscerotic disorders |
| 04/16/2013 | US8420777 Compounds that inhibit Hsp90 protein-protein interactions with IAP proteins |
| 04/16/2013 | US8420775 Polypeptides and methods for modulating D1-D2 dopamine receptor interaction and function |
| 04/16/2013 | US8420353 Humanized antibody and process for preparing same |
| 04/16/2013 | US8420348 Antibodies for the detection of integrin complexes in FFPE material |
| 04/16/2013 | US8420340 Identification of Actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases |
| 04/16/2013 | US8420339 Methods for predicting pregnancy outcome in a subject by hCG assay |
| 04/16/2013 | US8420099 Chimeric protein for prevention and treatment of HIV infection |
| 04/16/2013 | US8420095 Antigen-containing microspheres for the treatment of allergies |
| 04/16/2013 | US8420089 Antagonists of IL-6 to raise albumin and/or lower CRP |
| 04/16/2013 | US8420088 Methods and compositions using FGF23 fusion polypeptides |
| 04/16/2013 | US8420087 Interleukin-12 targeted to oncofoetal fibronectin |
| 04/16/2013 | US8420086 Camptothecin conjugates of anti-CD22 antibodies for treatment of B cell diseases |
| 04/16/2013 | US8420085 Anti-IGF-IR antibodies and uses thereof |
| 04/16/2013 | US8420084 Fully human antibodies specific to CADM1 |
| 04/16/2013 | US8420083 Antibodies to receptor for advanced glycation end products (RAGE) and uses thereof |
| 04/16/2013 | US8420082 Neutralizing antibodies against GDF-8 and uses therefor |
| 04/16/2013 | US8420081 Antibody formulations and methods of making same |
| 04/16/2013 | CA2568162C Binding molecules capable of neutralizing rabies virus and uses thereof |
| 04/16/2013 | CA2555694C Anti-epcam immunoglobulins |
| 04/16/2013 | CA2542507C Treatment of inflammatory bowel disease |
| 04/16/2013 | CA2478169C Human antibodies specific to kdr and uses thereof |
| 04/16/2013 | CA2465973C Posh nucleic acids, polypeptides and related methods |
| 04/16/2013 | CA2412504C Antigenic polypeptides |
| 04/16/2013 | CA2412052C Method for modifying plant morphology, biochemistry and physiology |
| 04/16/2013 | CA2361246C Identification of specific differentially expressed antigens |
| 04/16/2013 | CA2271783C Survivin, a protein that inhibits cellular apoptosis, and its modulation |
| 04/11/2013 | WO2013052926A2 Methods and compositions for single chain variable region enox2 antibodies for cancer detection and diagnosis |
| 04/11/2013 | WO2013052772A2 Anti-human sema4a antibodies useful to treat disease |
| 04/11/2013 | WO2013052155A1 Methods of treating liver conditions using notch2 antagonists |
| 04/11/2013 | WO2013051891A1 Anti c-met antibody and uses thereof |
| 04/11/2013 | WO2013051878A2 Antibody specifically binding to epitope in sema domain of c-met |
| 04/11/2013 | WO2013051606A1 Monoclonal antibody capable of specifically recognizing asparagine synthase |
| 04/11/2013 | WO2013051294A1 Antigen-binding molecule for promoting clearance from plasma of antigen comprising saccharide chain receptor-binding domain |
| 04/11/2013 | WO2013050725A1 Ige anti -hmw-maa antibody |
| 04/11/2013 | WO2013050567A1 Phosphospecific antibodies recognising tau |
| 04/11/2013 | WO2013050457A1 Characterization of cho-mif gene and protein, and use thereof |
| 04/11/2013 | WO2013050383A2 In vitro method to determine the risk of a pregnant woman of carrying a fetus with fetal aneuploidy |
| 04/11/2013 | WO2013050335A1 Process for antibody g1 glycoform production |
| 04/11/2013 | WO2013049931A1 Recombinant b. pseudomallei adhesin protein and methods and uses thereof |
| 04/11/2013 | WO2013024157A3 Combinations of anti -hcv - entry factor antibodies, protein kinase inhibitors or alisporivir for the treatment and the prevention of hcv infection |
| 04/11/2013 | WO2013024156A3 Combinations of anti-hcv-entry factor antibodies and interferons for the treatment and the prevention of hcv infection |
| 04/11/2013 | WO2013010085A3 Diagnosis, prognosis, and treatment of kidney disease |
| 04/11/2013 | WO2012170438A3 HUMAN ANTIGEN BINDING PROTEINS THAT BIND TO A COMPLEX COMPRISING β-KLOTHO AND AN FGF RECEPTOR |
| 04/11/2013 | WO2012154983A3 Systems and methods for anti-pax8 antibodies |
| 04/11/2013 | WO2012012759A3 Anti-tumor antigen antibodies and methods of use |
| 04/11/2013 | WO2011153416A3 Novel anti-s1p antibody variants of lt1009 |
| 04/11/2013 | US20130091591 Artery- and vein-specific proteins and uses therefor |
| 04/11/2013 | US20130090457 Toll-Like Receptor 3 Antagonists for the Treatment of Metabolic and Cardiovascular Diseases |
| 04/11/2013 | US20130090376 Antibodies to tumor associated proteins |
| 04/11/2013 | US20130089872 Anti-human trop-2 antibody having anti-tumor activity in vivo |
| 04/11/2013 | US20130089853 Fluorescent dyes |
| 04/11/2013 | US20130089561 Epitope regions of a thyrotrophin (tsh) receptor, uses thereof and antibodies thereto |
| 04/11/2013 | US20130089560 Bone morphogenetic protein receptor binding agents and methods of their use |
| 04/11/2013 | US20130089559 Binding members for human cytomegalovirus |
| 04/11/2013 | US20130089557 Antibody specifically binding to epitope in sema domain of c-met |
| 04/11/2013 | US20130089556 Anti c-met humanized antibody and uses thereof |
| 04/11/2013 | US20130089555 ANTI-FcRH5 ANTIBODIES AND IMMUNOCONJUGATES AND METHODS OF USE |
| 04/11/2013 | US20130089554 RON Binding Constructs and Methods of Use Thereof |
| 04/11/2013 | US20130089553 Method for making heteromultimeric polypeptides |
| 04/11/2013 | US20130089552 Acylglycerol acyltransferase-like protein mgat-x1 and uses thereof |
| 04/11/2013 | US20130089548 Method and compositions to induce apoptosis of tumoral cells expressing shh |
| 04/11/2013 | US20130089547 Hybrid Constant Regions |
| 04/11/2013 | US20130089544 Antibodies Directed to ERBB2 |
| 04/11/2013 | US20130089543 Monoclonal antibodies that bind or neutralize dengue virus |
| 04/11/2013 | US20130089542 Anti c-met antibody and uses thereof |
| 04/11/2013 | US20130089541 Antibodies with Enhanced or Suppressed Effector Function |
| 04/11/2013 | US20130089540 New Humanized Anti-CD20 Monoclonal Antibody |
| 04/11/2013 | US20130089537 Method for treating a disease associated with soluble, oligomeric species of amyloid beta 1-42 |
| 04/11/2013 | US20130089515 Use of IL-12 and IL-12 Antagonists in the Treatment of Autoimmune Diseases |
| 04/11/2013 | US20130089496 Tumor targeted antibodies and method for using the same |
| 04/11/2013 | CA2851244A1 Anti-human sema4a antibodies useful to treat disease |
| 04/11/2013 | CA2851220A1 Antibody specifically binding to epitope in sema domain of c-met |
| 04/11/2013 | CA2851135A1 Anti c-met antibody and uses thereof |
| 04/11/2013 | CA2850696A1 Monoclonal antibody specifically recognizing asparagine synthetase |
| 04/11/2013 | CA2850686A1 Phosphospecific antibodies recognising tau |
| 04/11/2013 | CA2849011A1 Methods of treating liver conditions using notch2 antagonists |
| 04/11/2013 | CA2848842A1 Ige anti -hmw-maa antibody |
| 04/10/2013 | EP2578688A1 ADAM6 mice |
| 04/10/2013 | EP2578682A1 Antibody and use thereof |
| 04/10/2013 | EP2578681A1 Iga-binding peptide and iga purification using same |
| 04/10/2013 | EP2578602A2 TCR-V-beta related peptides for treatment and diagnosis of autoimmune disease |
| 04/10/2013 | EP2578601A1 Immuno-based botulinum toxin serotype A activity assays |
| 04/10/2013 | EP2578600A2 RSV-specific binding molecules and means for producing them |
| 04/10/2013 | EP2578233A1 Therapeutic agent for pancreatic cancer |
| 04/10/2013 | EP2578232A1 Treatment drug for autoimmune diseases and allergic diseases |
| 04/10/2013 | EP2578231A1 Antitumor t cell response enhancer |
| 04/10/2013 | EP2576788A2 Cloning and exploitation of a functional r-gene from solanum x edinense |
| 04/10/2013 | EP2576623A2 Monoclonal antibodies detection methods for enzymes that confer resistance to 2,4-dichlorophenoxyacetic acid in plants |
| 04/10/2013 | EP2576622A1 ANTIBODIES DIRECTED TO THE UNPROCESSED RECEPTOR TYROSINE KINASE c-MET |
| 04/10/2013 | EP2576621A1 Monoclonal antibodies against her2 |
| 04/10/2013 | EP2576620A1 Single -chain variable fragment anti-cd133 antibodies and uses thereof |